Research and Markets: Drug-Eluting Stents - Global Strategic Business Report - 2011 Edition Profiles 39 Companies Including Many Key and Niche Players.
Business Wire › February 25, 2011
Linked as:
Business Wire › February 25, 2011
Linked as:Extract
Research and Markets: Drug-Eluting Stents - Global Strategic Business Report - 2011 Edition Profiles 39 Companies Including Many Key and Niche Players.
DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/7f0590/drugeluting_stent) has ann...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
Hormone Therapy Linked to Dying From Lung Cancer | Britain s Anglicans Open Door to Female Bishops | new years resolutions for the home keep designers busy | education grant to reward innovation | Sentencia nº 3994 de Consiglio di Stato, September 02, 2010 | Sentencia nº 1510 de Consiglio di Stato, March 25, 2009 | dictamen nº 57949 de contraloría general de la república de september 29 2010 | Dictamen nº 20708 de Contraloría General de la República, de April 21, 2009